GW Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.04.21	GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for Enterprise in Innovation (GlobeNewswire)
20.04.21	GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex (GlobeNewswire)
26.02.21	GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated with Tuberous Sclerosis Complex (GlobeNewswire)
04.02.21	BIIB Pulls Plug On Parkinson's Drug, JAZZ Acquires GWPH, NBIX Ends Deal With VYGR, TYME Flies (RTTNews)
03.02.21	Stock Alert: GW Pharma Surges 50% As Jazz Pharma To Takeover The Co. (RTTNews)
03.02.21	Jazz Pharma To Acquire GW Pharmaceuticals For $7.2 Bln - Quick Facts (RTTNews)
24.12.20	Canopy Growth Files Patent Infringement Lawsuit Against GW Pharmaceuticals (RTTNews)
03.11.20	Stock Alert: GW Pharmaceuticals Climbs 10% On Narrower Q3 Loss (RTTNews)
04.08.20	ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec. (RTTNews)
26.06.20	Biotech Stocks Facing FDA Decision In July 2020 (RTTNews)
24.06.20	GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug (GlobeNewswire)
02.03.20	GW Pharmaceuticals regains exclusive commercialisation rights to Sativex® (nabiximols) in the UK from Bayer (GlobeNewswire)
11.11.19	GW Pharma Receives Positive NICE Recommendation For EPIDYOLEX Oral Solution (RTTNews)
11.11.19	GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX® (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy (GlobeNewswire)
24.09.19	European Union Approves First Cannabis-based Medicine Epidyolex (RTTNews)
23.09.19	GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy (GlobeNewswire)
07.08.19	Guardant In Good Health, GW Pharma On Track, FLXN Abuzz (RTTNews)
26.07.19	GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX™ (cannabidiol oral solution) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy (GlobeNewswire)
28.08.18	GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology (GlobeNewswire)
26.06.18	FDA Approves 1st Cannabis-Based Drug, TECH Opens Wallet Again, MACK, SPHS Plunge (RTTNews)
23.06.18	An Ear To The Pharma: 15 Stocks To Watch (AKAO, PTIE, ASNS…) (RTTNews)
29.05.18	Biotech Stocks Facing FDA Decision In June (RTTNews)
21.04.18	An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDR…) (RTTNews)
20.04.18	ARGS Hit By Double Whammy, GWPH's Epidiolex Nears Approval, FDA Nod For AZN (RTTNews)
18.04.18	GWPH Faces FDA Panel Today, NVCR Reports STELLAR Data, 1st XLH Drug Cleared (RTTNews)
14.04.18	An Ear To The Pharma: 9 Stocks To Watch This Week (RIGL, RARE, TROV, DVAX...) (RTTNews)
05.04.18	KWHCoin Announces Partnership to Become the Largest Renewable Energy Blockchain in Puerto Rico (PR Newswire)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
28.03.18	Biotech Stocks Facing FDA Decision In April (RTTNews)
25.02.18	An Ear To The Pharma: 6 Stocks To Watch This Week (RTTNews)
22.02.18	ACIP Backs HEPLISAV-B, GMED Hits New High, GWPH's Focal Seizures Trial Fails (RTTNews)
25.01.18	ANIK, GWPH Hit Record High, Menlo To Make Stock Market Debut, IOVA On Watch (RTTNews)
19.01.18	A Rundown Of Dravet Syndrome Drugs In The Pipeline (RTTNews)
09.01.18	Revlon Announces New Global Brand Ambassador GAL GADOT (PR Newswire)
08.01.18	3PL Central Innovates the Third Party Logistics Industry With the Next Generation of 3PL Warehouse Manager (PR Newswire)
11.12.17	Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com (PR Newswire)
11.12.17	Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com (PR Newswire)
08.12.17	Starlight U.S. Multi-Family (No. 5) Core Fund Completes Strategic Recycling of Capital and Improves Portfolio Vintage with Acquisition in Dallas, Texas (PR Newswire)
05.12.17	Earny, The Automated Consumer Advocate Service, Raises $9 Million In Series A Funding (PR Newswire)
01.12.17	In The Spotlight: Zogenix (RTTNews)
22.11.17	OSUR Turns Heads, MRSN To Report Data By Year-end, CYTK Loses Vitality (RTTNews)
19.09.17	Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects (PR Newswire)
19.09.17	Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects (PR Newswire)
13.09.17	Biosynthesis Technology Could Transform Cannabinoid Production (PR Newswire)
13.09.17	Biosynthesis Technology Could Transform Cannabinoid Production (PR Newswire)
12.09.17	Cannabis Biotechs Taking Leading Stance in Global Marijuana Market (PR Newswire)
12.09.17	Cannabis Biotechs Taking Leading Stance in Global Marijuana Market (PR Newswire)
10.08.17	Biotech Influence on Cannabinoid-based Drug Development Leading to Latest Clinical Trials for Treatments for Chronic Disorders (PR Newswire)
10.08.17	Biotech Influence on Cannabinoid-based Drug Development Leading to Latest Clinical Trials for Treatments for Chronic Disorders (PR Newswire)
27.07.17	Biotech Players Lead the Growth Charge in the Legal Cannabis Market (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	88.94	7.57 %	K V
ABB	51.08	2.16 %	K V
CieFinRichemont	174.65	1.42 %	K V
Novartis	93.44	1.08 %	K V
Zurich Insur Gr	558.60	1.05 %	K V
Nestle	78.28	0.13 %	K V
Sika	231.80	-0.34 %	K V
Sonova Hldg	317.00	-0.47 %	K V
Givaudan	3’983.00	-1.02 %	K V
Lonza Grp	579.00	-2.62 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu GW Pharmaceuticals PLC American Deposit Share Repr 12 Shs

Aktien Top/Flop

Meistgelesene Nachrichten